학술논문
423PD - Phase I, open-label, dose-escalation study of SNX-5422 plus everolimus in neuroendocrine tumors (NETs)
Document Type
Abstract
Author
Source
In Annals of Oncology 1 October 2016 27 Supplement 6:vi138-vi138
Subject
Language
ISSN
0923-7534